GGoldman Sachs TTesla · TSLA

Goldman Sachs Reiterates Neutral on Tesla, $360 PT

Sep 15, 2026· 1 min read· Reproduced verbatim
Rating
Hold
Price target
$360
Previous
Implied upside
+0%

Goldman Sachs analyst Mark Delaney reiterated a Neutral rating and $360 price target on Tesla (NASDAQ: TSLA)

“We believe that Tesla’s 3Q26 vehicle deliveries are tracking below consensus (at 456K per Visible Alpha) and our prior view, and we lower our forecast to 435K from 490K.

This is based on monthly and/or weekly sales datapoints for key regions (e.g.

China, the US, and Europe), and we think that all three regions are tracking slower than we had previously expected.

However, some regions lled via exports from China (e.g. SE Asia, South America, Australia) are showing strength on yoy basis, which we think will partly mitigate the weakness.

However, typical seasonality in 4Q, plus the Model Y L ramp in the US and Europe, has the potential to help 4Q26 to improve qoq. We also think that FSD can be a driver of demand.

We now model 475K deliveries in 4Q26, down from 515K prior, but above consensus at 462K.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.